Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 11, November 1993 TABLE OF CONTENTS
  •  Online Features
  Clinical Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal


Are There Any Differences?

Barbara Kaplan, PharmD; Randall A. Swain, MD

Arch Fam Med. 1993;2(11):1167-1174.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal antiinflammatory drugs with upper gastrointestinal bleeding. Arch Intern Med. 1987;147:85-88. FREE FULL TEXT
2. The top 200 drugs of 1991. Am Druggist. 1992;2:48-56.
3. Facts and Comparisons: Loose Leaf Drug Information Service. St Louis, Mo: Facts and Comparisons Inc; 1991:251.
4. Hochberg MC. NSAIDs: patterns of usage and side effects. Hosp Pract (Off Ed). 1989;24:167-174. PUBMED
5. Williams HJ, Clegg DO. Basic therapy of rheumatoid arthritis: nonsteroidal anti-inflammatory drugs. Compr Ther. 1990;16:58-64. PUBMED
6. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities. N Engl J Med. 1991;324:1716-1725. PUBMED
7. AMA's Drug Evaluations. Chicago, Ill: American Medical Association; 1990;5:1-42.
8. Wasner C, Britton MC, Kraines RG, Kaye RL, Bobrove AM, Fries JF. NSAIDs in rheumatoid arthritis and ankylosing spondylitis. JAMA. 1981;246:2168-2172. FREE FULL TEXT
9. Drug Interactions & Updates. Vancouver, Wash: Applied Therapeutics Inc; 1991.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183. FREE FULL TEXT
11. Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988;297:1017-1021. FREE FULL TEXT
12. Simon LS. Toxicity of NSAIDs. Curr Opin Rheumatol. 1990;2:481-488. PUBMED
13. McCarthy DM. Misoprostol. Drug Ther. 1989;19:59-69.
14. Henry DA. Side effects of NSAIDs. Baillieres Clin Rheumatol. 1988;2:425-454. PUBMED
15. Summerville K, Faulkner G, Langman M. NSAIDs and bleeding peptic ulcer. Lancet. 1986;1:4624.
16. Fries JF, Miller SR, Spitz PA, Williams CA, Hubert HB, Bloch DA. Identification of patients at risk for gastropathy associated with NSAID use. J Rheumatol. 1990;17(suppl_20):12-19.
17. Paulus HE. Nonsteroidal anti-inflammatory drugs: major side effects. J Musculoskel Med. 1991;8(suppl 4):S29-S33.
18. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:256-263. FREE FULL TEXT
19. Laporte JR, Carne X, Vidal X, Moreno V, Juan J. Upper Gl bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs: Catalan countries study of upper Gl bleeding. Lancet. 1991;337:8733, 8785-8789.
20. Fries JF, Williams CA, Block DA. The relative toxictiy of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1991;34:1353-1360. PUBMED
21. Osborn TG. Oxaprozin compared with piroxicam for osteoarthritis. J Musculoskel Med. 1993;10(suppl 3):S33-S37.
22. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol. 1991;32:77-83. PUBMED
23. Roth S, Bennett R, Caldron P, et al. Reduced risk of NSAID gastropathy with nonacetylate salicylate (salsalate): an endoscopic study. Semin Arthritis Rheum. 1990:19(suppl 2):11-19. PUBMED
24. Cryer B, Goldschmiedt M, Redfern JS, Feldman M. Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins. Gastroenterology. 1990;99:1616-1621. PUBMED
25. Arnold JD. Assessing gastrointestinal safety of anti-inflammatory drugs. J Musculoskel Med. 1991;8(suppl 4):S54-S59.
26. Lanza FL, Arnold JD. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies. Clin Rheumatol. 1989;8(suppl 1):5-15. PUBMED
27. Sanda M, Jacob G, Shand DB. A safety profile of etodolac in arthritis: clinical experience based on 600 patient-years. Today's Ther Trends. 1985;3:1-15.
28. Roth SH. Nabumetone: a new NSAID for rheumatoid arthritis and osteo-arthritis. Orthop Rev. 1992;21:223-227. PUBMED
29. Lussier A, LeBel E. Radiochromium evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone. Am J Med. 1987;83(suppl 4B):15-18. PUBMED
30. Jenner PN. A post-marketing surveillance of nabumetone. Drugs. 1990;40(suppl 5):80-86.
31. Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol. 1987;82:1153-1158. PUBMED
32. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A. Double-blind placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine for tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology. 1988;995:289-294.
33. Lanza F, Peace K, Gustitus L, Rack MF, Dickson B. A blinded endoscopic comparative study of misoprostol vs. sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol. 1988;83:143-146. PUBMED
34. Graham DY, Aarawal N, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988;2:1277-1280. PUBMED
35. Henry D. Assessing the benefits and risks of drugs: the example of NSAIDs. Aust Fam Physician. 1990;19:378-387. PUBMED
36. Haylor J. Prostaglandin synthesis and renal function in man. J Physiol. 1980;298:382-396.
37. Carmichael J, Shankel SW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 1985;78:992-1000. PUBMED
38. Scharschmidt L, Simonson M, Dunn MJ. Glomerular prostaglandins, angiotensin II, and nonsteroidal antiinflammatory drugs. Am J Med. 1986;81(suppl 2B):30-42. PUBMED
39. Berg KJ, Talseth T. Acute renal effects of sulindac and indomethacin in chronic renal failure. Clin Pharmacol Ther. 1985;37:447-452. PUBMED
40. Bunning RD, Barth WF. Sulindac: a potentially renal-sparing nonsteroidal anti-inflammatory drug. JAMA. 1982;248:2864-2867. FREE FULL TEXT
41. Prescott LF. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs. 1982;23:75-149. PUBMED
42. Shelley JH. Pharmacologic mechanisms of analgesic nephropathy. Kidney Int. 1978;13:15-26. PUBMED
43. Nanna RS, Stuart-Taylor J, DeLeon AM, White KH. Analgesic nephropathy: etiology, clinical syndrome and clinicopathologic correlations in Australia. Kidney Int. 1978;13:79-92. PUBMED
44. The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics. JAMA. 1986;256:1749-1757. FREE FULL TEXT
45. 1992 Drug Topics Redbook. Montvale, NJ: Medical Economics Data Inc; 1992.